JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pozharskaya, V. P.
Right arrow Articles by Offermann, M. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pozharskaya, V. P.
Right arrow Articles by Offermann, M. K.
Journal of Virology, June 2004, p. 6621-6635, Vol. 78, No. 12
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.12.6621-6635.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Short Duration of Elevated vIRF-1 Expression during Lytic Replication of Human Herpesvirus 8 Limits Its Ability To Block Antiviral Responses Induced by Alpha Interferon in BCBL-1 Cells

Veronika P. Pozharskaya,1 Laura L. Weakland,1,{dagger} James C. Zimring,1,2 Laurie T. Krug,1 Elizabeth R. Unger,3 Andrew Neisch,2 Harish Joshi,4 Naoki Inoue,3,{ddagger} and Margaret K. Offermann1*

Winship Cancer Institute,1 Department of Pathology,2 Department of Cell Biology, Emory University, Atlanta, Georgia 30322,4 Centers for Disease Control and Prevention, Atlanta, Georgia 303333

Received 3 November 2003/ Accepted 6 February 2004

Human herpesvirus 8 (HHV-8) encodes multiple proteins that disrupt the host antiviral response, including viral interferon (IFN) regulatory factor 1 (vIRF-1). The product of the vIRF-1 gene blocks responses to IFN when overexpressed by transfection, but the functional consequence of vIRF-1 that is expressed during infection with HHV-8 is not known. These studies demonstrate that BCBL-1 cells that were latently infected with HHV-8 expressed low levels of vIRF-1 that were associated with PML bodies, whereas much higher levels of vIRF-1 were transiently expressed during the lytic phase of HHV-8 replication. The low levels of vIRF-1 that were associated with PML bodies were insufficient to block alpha IFN (IFN-{alpha})-induced alterations in gene expression, whereas cells that expressed high levels of vIRF-1 were resistant to some changes induced by IFN-{alpha}, including the expression of the double-stranded-RNA-activated protein kinase. High levels of vIRF-1 were expressed for only a short period during the lytic cascade, so many cells with HHV-8 in the lytic phase responded to IFN-{alpha} with increased expression of antiviral genes and enhanced apoptosis. Furthermore, the production of infectious virus was severely compromised when IFN-{alpha} was present early during the lytic cascade. These studies indicate that the transient expression of high levels of vIRF-1 is inadequate to subvert many of the antiviral effects of IFN-{alpha} so that IFN-{alpha} can effectively induce apoptosis and block production of infectious virus when present early in the lytic cascade of HHV-8.


* Corresponding author. Mailing address: Winship Cancer Institute, 1365-B Clifton Rd., N.E., Atlanta, GA 30322. Phone: (404) 778-5808. Fax: (404) 778-3965. E-mail: mofferm{at}emory.edu.

{dagger} Present address: Georgia Cancer Specialists, Atlanta, Ga.

{ddagger} Present address: Department of Virology I, National Institute of Infectious Disease, Tokyo, Japan.


Journal of Virology, June 2004, p. 6621-6635, Vol. 78, No. 12
0022-538X/04/$08.00+0     DOI: 10.1128/JVI.78.12.6621-6635.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2004 by the American Society for Microbiology. All rights reserved.